These results indicate that in our model, CD103 expression does not affect the type and polarity of the inflammatory response, and suggest a role for CD103 in regulating other mechanisms of HP pathophysiology and disease severity. This evidence concerns the gene ITGAE and hypersensitivity pneumonitis.